Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases. The company is focused on its programs in the hematology and genetic disease portfolios, which comprise different product candidates in its pipeline, such as BEAM-101, which is being developed to target Sickle Cell Disease, BEAM-302, a liver-targeting lipid nanoparticle, being developed to target Alpha-1 antitrypsin deficiency, and other drug candidates including BEAM-302, BEAM-103 & 104. The company views its operations and manages its business in one operating segment, operating exclusively in the United States.
Quick Stats
May 18, 202657.4
AI Score
HOLD0.94
Volume Ratio
May 12, 2026
Next Earnings
16
+ve Days (30d)
14
-ve Days (30d)
BEAM Stock Summary
Last updated May 18, 2026
BEAM is currently trading at $26.81, positioned above its 200-day moving average of $25.56, indicating a long-term uptrend. The stock has a 52-week range of $15.35 to $36.44.
Technical Analysis: The 50-day moving average stands at $27.72, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 40.175, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.203, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates BEAM at 57.4/100 with a HOLD recommendation.
BEAM (Beam Therapeutics Inc. Common Stock) Indicators
Last updated May 18, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 40.175 |
| CMF (20) | -0.203 |
| ROC (10) | -11.702 |
| ADX (14) | 16.464 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 0.265 |
| AROONOSC (14) | -35.714 |
| WILLAMS %R (14) | -98.364 |
| MFI (14) | 62.037 |
BEAM Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
BEAM Price vs Max Options Open Interest
BEAM Max Change In Options Open Interest
BEAM Options - Sort by Max open Interest (near term)
18th May 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
BEAM Daily Out of Money Options - Sort by Max open Interest (near term)
18th May 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
BEAM Daily In the Money Options - Sort by Max open Interest (near term)
18th May 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
BEAM Most Active Options by Volume(near term)
18th May 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Beam Therapeutics Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
BEAM Moving Averages Analysis
Beam Therapeutics Inc. Common Stock has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on May 18, 2026
BEAM (Beam Therapeutics Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated May 18, 2026
| Days | MA |
|---|---|
| 10 | 30.45 |
| 20 | 30.22 |
| 30 | 29.74 |
| 50 | 27.72 |
| 100 | 28.25 |
| 200 | 25.56 |
BEAM Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 2.9 billion |
| Earnings/Share ($) | -0.49 |
| Net Proft Margin (%) | -0.4023 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -4.5057 |
| EPS Estimate Next Year ($) | -4.8171 |
| WallStreet Target Price ($) | 51.0667 |
| Most Recent Quarter |